Ugliest month for Aussie stocks since 2015 Ugliest month for Aussie stocks since 2015 Ugliest month for Aussie stocks since 2015

Ugliest month for Aussie stocks since 2015

Equities 6 minutes to read

Summary:  The factors behind the recent weakness in equities are structural and profound, and volatility could pick up further as we head into 2019.

October has been an ugly month for global equities, erasing the year’s gains across multiple indexes. The ASX 200 has not escaped the global sell-off and month-to-date losses of 6.08% make October 2018 the worst month since August 2015 for the index. 

On October 3, Federal Reserve chair Jerome Powell jinxed stocks when he stated that we remain “a long way” from neutral; the market then essentially flipped from record complacency to panic. The sharp rise in US 10-year yields to a seven-year high above 3.2% at the start of the month caused market participants to sharply reconsider asset prices as Treasury rates are the foundation for valuation across all asset classes. 

October progressed against a backdrop of rising rates, rising political risk into the US midterm elections, trade war, European issues relating to Brexit and the Italian budget, and the US earnings season highlighting a peak in corporate profit growth and margin expansion. The simultaneous unwind in positioning has been violent given positioning before the sell-off. In such a situation of crowded positioning, once momentum rolls over, the floor essentially drops with everyone running for the exit at the same time. 

The sudden rise in real yields drove the rate increase, not inflation expectations. This is important as rising real yields calls valuations into question. As the discount rate rises, this acts like gravity on growth stocks, a segment typically heavily weighted towards technology stocks. On the ASX 200, though, the healthcare sector also falls into this cohort of high-growth/high-PE stocks deriving their present value from future cashflows. 

High-growth stocks are hit hardest as their lofty valuations arise from the prospect of high future earnings. As the discount rate rises, this erodes the value of such shares because the present value of high earning streams is worth less once discounted. The Nasdaq is on course for its worst month since 2008 as these dynamics play out in real time. The negative sentiment and discount rate dynamic has flowed through into the ASX with the Australian tech sector, taking its lead from Wall Street, being the worst performer throughout the month of October. Tech was closely followed by healthcare, another victim to the reversal of growth/high PE positioning.
ASX 200
Source: Bloomberg, Saxo Bank
The energy sector has also fallen short this month with Brent crude down 6.7% and WTI down 9.3. Commodities, as Saxo Head of Commodity Strategy Ole Hansen recently noted, have failed to defend the global equity rout against their own backdrop of rising rates, stronger dollar, and concerns regarding global growth and commodity demand.

As oil prices increased and Brent crude hit highs of $86/barrel in early October, the risk of demand destruction rose as well, particularly within the emerging economies that account for a large proportion of demand growth for oil. For example, in India, given the strong USD and rupee depreciation year-to-date, the price of oil in local currency terms has risen to levels not seen since 2014 when oil was trading above $100. Throw in Saudi Arabia’s pledge to produce as much as possible and Opec’s concerns about oversupply and we have seen a dramatic turnaround from the $100/b oil forecasts seen not so long ago.

Higher bond yields also start to call into question positioning in equity markets and asset allocation more broadly as risk premium rises and yields approach levels that start to compete with dividend yields, meaning that risk reward becomes less attractive for equities in general. For a conservative investor, the yield on a two-year note or one-year bill for a conservative investor is getting to levels where it can compete with stocks’ dividend yields, bringing about a seismic shift in asset allocation that only adds pressure to equity markets. The ‘buy the dip’ strategy that has worked all year is now much riskier.

Investors will be rewarded for positioning cautiously against this backdrop and overweighting defensive sectors within equities. In terms of factor exposure, we see sentiment tilting towards low beta/minimum volatility, quality, and value (which can be played through ETFs and by reducing exposure to high PE, momentum, and high beta positioning). The VIX is still above 22, which is statistically a short-term negative for equity markets.

The silver lining is that we could see another push higher for equity markets before year-end, but any rally will be shorter lived than its predecessors. Following a final push, equity markets will succumb to ever-increasing headwinds and significantly lower earnings growth next year. We are approaching a seasonally strong period for financial markets; going back to 1930, the average November-December price change for the S&P 500 in midterm election years is 3.5% (according to Bloomberg data). We also note that the buyback blackout period is ending, and global growth, while decelerating, is not actually contracting. Global equities are pricing in the worst-case economic outcome heading into a seasonally strong period, which could lead to some positivity into the end of the year.

Fast forward into 2019, though, and US equities look dangerous. We will have slowing repatriation of funds and fewer buybacks (which have artificially suppressed US equity volatility and buoyed the stock market), peak profit margins as the fiscal stimulus fades, and rising input costs rising due to energy, wages, and tariffs. 2019 has the potential to be a tumultuous year for all asset classes with maximum Fed tightening, draining dollar liquidity, and rising interest rates. Volatility will likely increase in intensity as the Fed moves further into a financially restrictive phase throughout 2019.


The Saxo Group entities each provide execution-only service, and access to analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Inspiration Disclaimer and (v) Notices applying to Trade Inspiration, Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular, no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (
Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region


Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.